Results 31 to 40 of about 1,187,146 (230)

Structures and biological functions of IL-31 and IL-31 receptors [PDF]

open access: yesCytokine & Growth Factor Reviews, 2008
Interleukin-31, produced mainly by activated CD4(+) T cells, is a newly discovered member of the gp130/IL-6 cytokine family. Unlike all the other family members, IL-31 does not engage gp130. Its receptor heterodimer consists of a unique gp130-like receptor chain IL-31RA, and the receptor subunit OSMRbeta that is shared with another family member ...
Qing, Zhang   +4 more
openaire   +2 more sources

Interleukin-31 new biomarker of infectious skin diseases

open access: yesJournal of V. N. Karazin Kharkiv National University: Series Medicine, 2021
Introduction. The introduction of antiretroviral therapy has significantly improved the long-term prognosis of AIDS patients, but opportunistic infections can still be life-threatening for this population.
Diana Dorosh
doaj   +1 more source

The IL-31/IL-31 receptor axis: general features and role in tumor microenvironment [PDF]

open access: yesJournal of Leukocyte Biology, 2017
Abstract IL-31 is a recently identified cytokine with a well-defined role in the pathogenesis of pruritus. IL-31, whose production is induced by IL-4 and IL-33, binds a heterodimeric receptor (R) composed of the exclusive IL-31RA chain and the shared oncostatin M R.
Elisa, Ferretti   +2 more
openaire   +2 more sources

Pathogenesis of Atopic Dermatitis: Current Paradigm [PDF]

open access: yesIranian Journal of Immunology, 2019
Atopic dermatitis (AD) is characterized by skin inflammation, barrier dysfunction and chronic pruritus. In this review, recent advances in the pathogenesis of AD are summarized.
Masutaka Furue   +5 more
doaj   +1 more source

In dogs with atopic skin disease, is lokivetmab more effective than oclacitinib in reducing the score of a recognised scoring system?

open access: yesVeterinary Evidence, 2022
PICO question In dogs with atopic skin disease, is lokivetmab more effective than oclacitinib in reducing the Canine Atopic Dermatitis Lesion Index score (or some other recognised scoring system)?
Bonnie Yuan Tone Cheung
doaj   +1 more source

Dupilumab for cancer-associated refractory pruritus

open access: yesJournal of Allergy and Clinical Immunology: Global, 2023
Background: Pruritus can be an intolerable symptom in patients with cancer. Type 2 inflammation, and specifically, the cytokines IL-4, IL-13, and IL-31, play major roles in the itching process.
Aviv Talmon, MD   +8 more
doaj   +1 more source

Interleukin-31 in serum and cerebrospinal fluid of dogs with syringomyelia

open access: yesBMC Veterinary Research, 2023
Background Syringomyelia is a spinal cord cavity containing cerebrospinal fluid (CSF)-like fluid. If syringomyelia asymmetrically involves the dorsal horn grey matter of the spinal cord, affected dogs show increased signs of dysesthesia and neuropathic ...
Laura Lemke   +6 more
doaj   +1 more source

Microbiota and IL-33/31 Axis Linkage: Implications and Therapeutic Perspectives in Atopic Dermatitis and Psoriasis

open access: yesBiomolecules, 2023
Microbiome dysbiosis and cytokine alternations are key features of atopic dermatitis (AD) and psoriasis (PsO), two of the most prevalent and burdensome pruritic skin conditions worldwide.
Laura Bonzano   +5 more
doaj   +1 more source

IL-31 and IL-33 in rheumatoid arthritis patients

open access: yesНаучно-практическая ревматология, 2022
Objective – to investigate clinical and diagnostic significance of IL-31 and IL-33 determination in patients with rheumatoid arthritis (RA).Material and methods. 154 patients with a reliable diagnosis of RA were examined.
N. A. Lapkina   +8 more
doaj   +1 more source

Immune response in atopic dermatitis: main pathogenetic mechanisms and stage-dependent correlations with age in regard to dermatological and non-dermatological systemic processes

open access: yesМедицинская иммунология, 2021
Atopic dermatitis is one of the most common chronic inflammatory skin diseases caused by both terminal defects in keratinocyte differentiation, and pronounced type 2 immune responses.
M. B. Drozhdina, E. V. Suslova
doaj   +1 more source

Home - About - Disclaimer - Privacy